DOCSLIB.ORG

265 Lesion-Continued Occlusive Arteriovascular-See Thrombosis

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
265 Lesion-Continued Occlusive Arteriovascular-See Thrombosis DISEASES AND NATURE OF INJURY 265 Lesion-continued Lethargy, negro 121.0 occlusive Letterer-Siwe disease 202.1 arteriovascular-see Thrombosis, Leuc(o)-for any term beginning thus artery -see Leuk(o) artery-see Thrombosis, artery Leukffimia, leukemia, leukffimic, peptic 545 leukemic 204.4 perirectal 578 acute (any type, except monocytic) pigmented 716 204.3 polypoid-see Polyp adellia 204.0 prechiasmal (optic) 388 acute 204.3 primary-see Syphilis, primary adenitis 204.0 pulmonary 527.2 acute 204.3 valve-see Endocarditis, pulmo- aleukffimic, aleukemic 204.4 nary acute 204.3 pylorus 545 lymphoid 204 0 radium NEe N993 acute 204.3 rectosigmoid 578 aleupenic 204.4 sacro-iliac joint 736 acute 204.3 secondary-see Syphilis, secondary atypical 204.4 sigmoid 578 acute 204.3 skin 716 cutis 204.4 spinal cord 357 acute 204.3 traumatic (complete) (incom­ eosinophilic 204.1 plete) (transverse) N958 acute 204.3 with granulocytic 204.1 broken back, neck N806 acute 204.3 fracture, spine or vertebra infiltration, retina 204.4 (cervical) (coccyx) lymphatio 204.0 (lumbar) (neural arch) acute 204.3 (sacral) (spinous or myelogenous 204; 1 transverse process) aoute 204.3 (thoracic) N806 labvrinth 204.4 spleen 298.1 acute 204.3 stomach 545 leukopenic 204.4 syphilitic-'---:see Syphilis aoute 204.3 tertiary-see Syphilis, tertiary lymphatic 204.0 tonsillar fossa 510.0 aoute 204.3 with tonsillectomy 510.1 aleukffimic. aleukemic 204.0 traumatic-see specified injury; if aoute 204.3 unspecified-see Injury lachrymal. lacrimal gland 204.0 tricuspid (valve)-see Endocarditis, aoute 204.3 tricuspid lymphoblastio 204.0 trigeminal nerve 361 acute 204.3 ulcerated or ulcerative-see Ulcer lymphocytio 204.0 uterus 633 acute 204.3 complicating delivery 677 chronio 204.0 vagus nerve 367 lymphogenous 204.0 valvular-see Endocarditis acute 204.3 vascular 456 lymphoid 204.0 following trauma N995.3* acute 204.3 warty 696 chronic 204.0 Lethargic megakaryocytic 204.4 encephalitis (acute) (infectious) acute· 204.3 082.2 mixed (cell) 204.2 late effects-see Encephalitis, monoblastic (acute) 204.2 infectious (acute), late monocytic (acute) 204.2 effects monocytoid myelogenous 204.1 meningomyelitis 082.2 aoute 204.3 late effects-see Encephalitis, myeloblastic 204.1 infectious (acute), late effects acute 204.3 268 INDEX Lipoid-continued Loasis 127 proteinosis of Urbach 289.0 Lobe, lobar-see condition Lipoidremia, lipoidemia 289.0 Lobstein's Lipoidosis 289.0 cancer 159 cerebrospinal 289.0 disease 758.3 cholesterol 289.0 Lobster-claw hand 759.1 diabetic 260 Lobulation (congenital) Lipoma (multiple) (subcutaneous) kidney fetal, fretal 757.3 226 liver, abnormal 756.2 thyroid gland 226 spleen 759.3 Lipomatosis (embryonal) 226 Lobule, lobular-see condition kidney 226 Local, localized-see condition Lipomyoma 226 Locked bowel or intestine 570.5 Lipomyosarcoma-see also Neoplasm, with hernia-see Hernia with intes- connective tissue, malignant tinal obstruction hilum of kidney 180 Locking Joint 738 perirenal 180' Lockjaw (see also Tetanus) 061 renal pelvis 180 Locomotor ataxia (progressive) 024 Lipomyxoma 226 Loffler's syndrome 245 Lipomyxosarcoma-see Neoplasm, Loiasis 127 connective tissue, malignant Lone star fever 104 Liposarcoma-see Neoplasm, connec­ Long flap, hymen 757.2 tive tissue, malignant Longitudinal stripes or grooves, nails Lipping 712 cervix 633 Loose-see also condition spine 723.1 bodies in joint 738 vertebra 723_] body sheath, tendon 744.2 Lipuria 789.3 cartilage (joint) 738 bilharziasis 123.0 sesamoid, joint 738 Lisping (nonorganic origin) 326.2 Loosening epiphysis 733 secondary to organic lesion 781.6 Lorain's disease or syndrome 272 Lissauer's paralysis 025 Lordosis (acquired) (congenital) 745 Lissencephalia 753.1 with cardiac failure or heart disease Lissencephaly 753.1 (conditions in 434.1, 434.2, Listerellose 064.4 434.4 or 782.4) 434.0 Listeriose 064.4 with hypertension-see Hyper­ Lithremia, lithemia 788.9 tension, heart Lithiasis-see also Calculus due to posture (incorrect) 745 hepatic 584 with cardiac failure or heart urinary 604 disease (conditions in 434.1 Lithoclasty 604 434.2, 434.4 or 782.4) Litholapaxy 604 434.0 Lithopedion-see Ectopic gestation with hypertension-see Hyper­ Lithosis (occupational) 523.0 tension, heart with tuberculosis 001 late effect nonoccupational 525 acute poliomyelitis 081 with tuberculosis 002 rickets 284 Lithotomy 604 rachitic 284 Lithotrity 604 tuberculous (active) 012.0 Lithuria 789.8 inactive, arrested, cured, healed, Little's disease (cerebral palsy) 351 late effect, sequela 013.0 Littre's Loss gland-see condition appetite 784.0 hernia-see Hernia control, sphincter, rectum 785.7 Littritis 607 extremity or member, traumatic, Livedo (reticularis) 782.3 current---see Amputation, Liver-see condition traumatic Livida asphyxia - 1 yr. 762.0 fluid, acute 788.0 with immaturity 762.5 hearing (complete )-see Deafness Loa loa 127 memory 780.8 DISEASES AND NATURE OF INJURY 269 Loss-continued Luxation-see also Dislocation mind 309 eyeball due to birth injury 761.0 late effect, acute infectious ence- with immaturity 761.5 phalitis 083_2 genital organs, external NEC N878 organ or part-see Absence labium (majus) (minus) N878 sense, smell, taste or touch 781.7 lachrymal, lacrimal gland (postin- sight (complete)-see Blindness fectional) 388 substance of lens (partial) (old) 388 cartilage 738 congenital 753.1 vitreous (humor) (humour) 388 spontaneous 388 voice 783.5 penis N878 weight 788.4 scrotum N878 Louping ill 082.0 testis N878 late effects-see Encephalitis, infec­ vulva N878 tious (acute), late effects Lycanthropy 309 Lousiness 136 late effect, acute infectious ence­ Low phalitis 083.2 basal metabolic rate 788.9 Lymph blood pressure 467.0 gland or node-see condition cardiac reserve-see Disease, heart scrotum 127 frequency deafness-see Deafness Lymphadenia, aleukremic, aleukemic function 204.0 kidney 603 acute 204.3 liver 583 Lymphadenitis 468.2 hremoglobin, hemoglobin 293 with lying kidney 603 abortion-see Abortion with reserve kidney 603 sepsis Lower extremity-see condition ectopic gestation 645.1 Ludwig's abdomen 468.2 angina 538 tuberculous OIl disease 538 acute 694 Lues (venerea), luetic-(8ee also Sy- aleukremic, aleukemic 204.0 philis) 029 acute 204.3 acquired 029 axillary 468.2 hereditary 020.2 tuberculous 015 infantum 020.2 breast, puerperal, postpartum, child­ Lumbago 726.0 birth 689 Lumbar-see condition bronchial, tuberculous (with symp­ Lumbarization, vertebra 758.5 toms) 005 Lumbermen's itch 137 without symptoms-see YOO.l Lunacy 309 cervical (pyogenic) 468.2 late effect, acute infectious ence- tuberculous 015 phalitis 083.2 chancroidal 036 Lung-see condition chronic 468.0 Lupoid miliary of Boeck 138.0 mesenteric 468.1 Lupus (tuberculous) 014.2 due to Cazenave's 705.4 anthracosis (occupational) 524 discoid 705.4 with tuberculosis 001 erythematodes (discoid) 705.4 nonoccupational 525 erythematosus (discoid) 705.4 with tuberculosis 002 disseminated 456 diphtheria (toxin) 055 exedens 014.2 generalized 468.2 Hilliard's 014.2 gonorrheal, gonorrhreal chronic non-tuberculous 705.4 034 pernio 138.0 infectional 468.2 vulgaris 014.2 inguinal 468.2 Lutembacher's disease or syndrome due to 754.3 chancroid 036 Luxatio bulbi due to birth injury 761.0 gonorrhea, gonorrhrea 030 with immaturity 761.5 lymphopathia venereum 037 270 DID EX T,ymphadenitis-contimled I Lymphallgitis--continued inguinal-continued chancroidal 036 tuberculous 015 chest wall 693.1 mediastinal, tuberculous (with face 693.0 symptoms) 005 finger 693.6 without symptoms-see YOO.l foot 693.5 mesenteric (non specific) 468.1 forearm 693.2 due to Bacillus typhi 040 gangrenous 693.6 tuberculous 011 hand 693.3 puerperal, postpartum, childbirth head 693.0 681 heel 693.5 purulent 468.2 hip 693.4 streptococcal 468.2 knee 693.4 subacute 468.2 leg 693.4 syphilitic multiple sites 693.6 early 021.4 neck 693.0 late 027 nose cxternal 693.0 tracheobronchial 468.2 pelvic, male 576 tuberculous (with symptoms) penis 005 acute 617 without symptoms-see YOO.l gonococcal (acute) 030 tuberculous-see Tuberculosis, chronic 031 lymph gland perineum 693.1 venereal 037 puerperal, postpartum, childbirth Lymphadenoid goiter, goitre 254 681 Lymphadenoma 201 scalp 693.0 multiple 201 shoulder 693.2 spleen 201 specified sites NEe 693.6 Lymphadenopathy (general) (ingui­ strumous, tuberculous 015 nal) 782.7 thigh 693.4 Lymphadenosis 201 thoracic duct 693.1 Lymphangiectasis 468.3 thumb 693.6 conjunctiva 468.3 toe 693.6 postinfectional 468.3 trunk 693.1 scrotum 468.3 tuberculous-see Tuberculosis, Lymphangiectatic elephantiasis, non· lymph gland filarial 468.3 mnbilicus Lymphangio-endothelioma 228 newborn 767.0 malignant--see Neoplasm, cOnJ1PC­ with immaturity 767.5 tive tissue, malignant 1 yr. + 693.1 Lymphangiofibroma 228 upper arm 693.2 Lymphangioma (congenital) 228 urachus 693.1 causing eyst of spleen 228 uterine ligament 626 circumscriptum 228 with Lymphangiomatous cyst, va,!.rina 228 abortion-see Abortion with Lymphangiosarcoma--.see ~eopla81ll. sepsis connective ti">ilH'. maligmint ectopic gestation 645.1 Lymphangitis (acute) (ehronie) (with pregnancy 641 abscess or eellnlitif') 693.6 puerperal, postpartum, childbirth with 681 abortion-see Abortion with wri"t 693.3 sepsis Lymphatic-see condition ectopi41 gestation 645.1 Lymphatism 273 abdominal wall 693.1 scrofulous 015 ankle 693.4 Lymphatocele 228 arm 693.2 Lymphedema (see also Elephantiasis) back 6!l3.1 468.3 breast puerperal, postpartum. child· Lymphendothelioma 228 birth 689 maligllant--see Neoplasm. COlll1eC­ buttock 693.1 tive tissue, malignant DISEASES AND
Load more

Recommended publications
  • ANNNNNNNNNNNNNNNNNNNN 100A 006 Left Eye Input Right Eye Input
    US 20190175049A1 ( 19) United States (12 ) Patent Application Publication (10 ) Pub. No. : US 2019 /0175049 A1 Welling ( 43 ) Pub . Date : Jun . 13 , 2019 ( 54 ) TECHNIQUES FOR ANALYZING (52 ) U . S . CI. NON -VERBAL MARKERS OF CONDITIONS CPC . .. A61B 5 /04842 (2013 . 01 ) ; A61B 5 / 7289 USING ELECTROPHYSIOLOGICAL DATA (2013 . 01) ; A61B 5 /0478 ( 2013 .01 ) ; A61B 5 /7225 ( 2013. 01 ) ; G06N 20 / 10 (2019 .01 ) (71 ) Applicant: Massachusetts Institute of Technology , Cambridge , MA (US ) ( 57 ) ABSTRACT (72 ) Inventor : Caroline Welling, Hanover, NH (US ) Embodiments related to analyzing brain activity of a subject to identify signs associated with binocular rivalry . Sensed ( 21 ) Appl. No. : 16 / 206, 639 electrical activity of a subject' s brain is received over a time period while the subject is exposed to a visual stimulus. The ( 22 ) Filed : Nov. 30 , 2018 sensed electrical activity comprises a first frequency band Related U . S . Application Data associated with a first frequency of a first image presented to the subject ' s left eye , a second frequency band associated (60 ) Provisional application No .62 / 593 , 535, filed on Dec . with a second frequency of a second image presented to the 1 , 2017 subject ' s right eye . A set of events in the time period is determined based on the frequency bands, wherein an event Publication Classification is associated with a change from a previous perceptual event (51 ) Int. Ci. to a new perceptual event. A metric for the subject is A61B 5 /0484 ( 2006 .01 ) determined based on the set of events . The metric is ana A61B 5 /00 ( 2006 .01 ) lyzed to determine whether the subject exhibits signs asso GO6N 20 / 10 (2006 .01 ) ciated with a condition that is associated with binocular A61B 5 /0478 ( 2006 .01 ) rivalry .
    [Show full text]
  • Sulphonmethane, Sulphonal, Diethylsulpho
    is a combination of amylene hydrate and chloral hydrate, superior to the corresponding compounds of other elements. while chloralose, a combination of chloral hydrate and glucose, Experience has shown that, in the main, these claims were un- partakes of the action of morphin and is rather expensive. founded, though many, even now, claim that strontium bro- Chloretone, a more recent product, is not entirely devoid of mid disturbs the stomach less than the corresponding sodium danger and is not always so certain in its action as chloral or potassium salt. Another claim that is frequently made by hydrate, while butyl chloral hydrate, or crotón chloral hydrate, manufacturers of nostrums, like "Peacock's Bromides," is that is one of the older compounds that has been found wanting and they use "chemically pure" salts. Exactly what is meant by is now little used. Of the official compounds of this group we this claim is difficult to say, but the Pharmacopeia gives us a have: number of readily applied tests by which the salts themselves Chloralamid and Paraldehyd. may be tested. The manufacturers of nostrums, on the other Chlobalformamidum.—TJ. S.—Chloralformamid. Chlorala- hand, not infrequently add the very substances that are consid- mid. This has practically the same action as therapeutic ered contaminations. doses of chloral hydrate, the latter being formed in the body by {To be continued.) decomposition of chloralformamid. Average dose: 1 gm. (15 grains). Paraldehtdum.—TJ. S.—Paraldehyd is slower in its action transparent liquid, slower in its action than chloral hydrate, but also safer. It has the disadvantage of a persistently dis- A NEW NEEDLE HOLDER.
    [Show full text]
  • 31V March 1891 — Insomnia As a Disease Per Se and As a Symp¬
    SYMPTOMATIC A' N D IDIOPATHIC INSOMNIA. ITS ETIOLOGY AND TREATMENT. B Y GEORGE DOUGLAS GRAY, M.B. 00O00O00O00 — 31V March 1891 — Insomnia as a disease per se and as a symp¬ tom of many diseases I have chosen as the subject of this thesis for several reasons. I have suffered . much from it myself and consequently have examined with more than ordinary clinical interest every case that has come under my notice, and in addition I have j found that, with the exception of odd notes in the medical journals, the literature on this subj.ect is comparatively rare. During this last half century since the introduction of steam power, and follov/lng it , the I "telegraph, electricity in its numerous forms, not to mention countless other time-saving devices, and with - an ever increasing population, competition or the race for life has become keener than at any " previoxis time, j -. : <■ , •- : 'V ■ " ■ ■ . - I The average human being lives at a very high pressure,! and this struggle for existence, with its concomitant 1 worries, has of late made Insomnia a much more fre¬ quent complaint than before. Indeed, in several of the older text-books on Practice of Physic (e.g. that of Dr. Hughes Bennet, published as lately as 1853) the subject is not even mentioned. In order to work well we must eat well and sleep well: loss of appet¬ ite and lowering of all bodily functions soon follow loss of sleep,therefore all the more important is it that the etiology and treatment of Insomnia should be thoroughly understood.
    [Show full text]
  • Wildlife Diseases and Humans
    Robert G. McLean Chief, Vertebrate Ecology Section Medical Entomology & Ecology Branch WILDLIFE DISEASES Division of Vector-borne Infectious Diseases National Center for Infectious Diseases AND HUMANS Centers for Disease Control and Prevention Fort Collins, Colorado 80522 INTRODUCTION GENERAL PRECAUTIONS Precautions against acquiring fungal diseases, especially histoplasmosis, Diseases of wildlife can cause signifi- Use extreme caution when approach- should be taken when working in cant illness and death to individual ing or handling a wild animal that high-risk sites that contain contami- animals and can significantly affect looks sick or abnormal to guard nated soil or accumulations of animal wildlife populations. Wildlife species against those diseases contracted feces; for example, under large bird can also serve as natural hosts for cer- directly from wildlife. Procedures for roosts or in buildings or caves contain- tain diseases that affect humans (zoo- basic personal hygiene and cleanliness ing bat colonies. Wear protective noses). The disease agents or parasites of equipment are important for any masks to reduce or prevent the inhala- that cause these zoonotic diseases can activity but become a matter of major tion of fungal spores. be contracted from wildlife directly by health concern when handling animals Protection from vector-borne diseases bites or contamination, or indirectly or their products that could be infected in high-risk areas involves personal through the bite of arthropod vectors with disease agents. Some of the measures such as using mosquito or such as mosquitoes, ticks, fleas, and important precautions are: tick repellents, wearing special cloth- mites that have previously fed on an 1. Wear protective clothing, particu- ing, or simply tucking pant cuffs into infected animal.
    [Show full text]
  • THE INTERDEPENDENCE of TROPICAL MEDICINE and GENERAL MEDICINE by GEORGE CHEEVER SIIATTUCK, M.D.Fl INTRODUCTION Water Fever, Cholera, Dysentery, Plague and Lep- Rosy
    TheMassachusettsMedicalSociety THE ANNUAL DISCOURSE* THE INTERDEPENDENCE OF TROPICAL MEDICINE AND GENERAL MEDICINE BY GEORGE CHEEVER SIIATTUCK, M.D.fl INTRODUCTION water fever, cholera, dysentery, plague and lep- rosy. Among them are other names which President and Fellows the Massachusetts may Mr. of appear new or such as Medical strange, oroya fever, Society: sodoku, or tsutsugamushi disease. It may be a you so kindly asked me to address surprise to find nearly two pages of references WHENyou on this occasion I assumed that you to rabies, and a few, respectively, to pneumonia, would wish to hear about the subject which has small-pox, tuberculosis, and typhus fever. absorbed most of my attention during the past As interpreted by the "Bulletin" the term seven years, namely, tropical medicine. Suppos- "tropical disease" is inclusive. It covers dis- ing that you might like to know something of eases of limited but not tropical distribution the background of this address I venture to say such as Rocky Mountain fever, as well as mal- that my first, contact with the subject was made adies like smallpox, typhus fever and rabies twenty years ago on a trip to the Par East. which modern hygiene knows how to banish and Later, in 1915, I saw much typhus fever, malaria, which, in consequence, are more likely to be relapsing fever, and papataci fever in Serbia.t found today in backward communities in the In 1921 I joined the Department of Tropical tropics than in highly civilized parts of the Medicine at Harvard, started a Service for Trop- temperate zone.
    [Show full text]
  • Controlled Substances Included; Rules. Sec. 7216
    PUBLIC HEALTH CODE (EXCERPT) Act 368 of 1978 333.7216 Schedule 3; controlled substances included; rules. Sec. 7216. (1) The following controlled substances are included in schedule 3: (a) Unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system, including their salts, isomers, including optical, position, or geometric isomers, and salts of the isomers if the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation: Benzphetamine Mediatric tabs Chlorphentermine Mediatric liquid Clortermine Phendimetrazine Edrisal tabs Special formula 711 tabs Genegesic caps Thora Dex No. 1 tab Hovizyme tabs Thora Dex No. 2 tab Mazindol (b) Unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances having a potential for abuse associated with a depressant effect on the central nervous system, including their salts, isomers, including optical, position, or geometric isomers, and salts of the isomers if the existence of the salts, isomers, and salts of isomers is possible within the specific chemical designation: Chlorhexadol Phencyclidine Glutethimide Sulfondiethylmethane Lysergic acid Sulfonethylmethane Lysergix acid amide Sulfonmethane Methyprylon (c) Nalorphine. (d) Any substance that contains any quantity of a derivative of barbituric acid, or any salt of a derivative of barbituric acid, except those substances that are specifically listed in other schedules. (e) A compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital, or a salt of amobarbital, secobarbital, or pentobarbital, and 1 or more other active medicinal ingredients that are not listed in a schedule.
    [Show full text]
  • Systematic Bacteriology for Pharmacy Students
    2015-10-27 Systematic Bacteriology for Pharmacy Students Spirochetes & other Spiral Bacteria Instructor: Mohsen Amin General Characteristics • Long, slender, helically coiled, motile • Endoflagella (axial filaments) • A series of cytoplasmic tubules • Three human pathogens 1. Treponema 2. Borrelia 3. Leptospira Treponema • T. pallidum subsp. pallidum causes syphilis • T. pallidum subsp. pertenue causes yaws • T. pallidum subsp. endemicum causes endemic syphilis (bejel) • T. carateum causes pinta 1 2015-10-27 Treponema pallidum • Morphology: regular spiral coils, 0.2 µm x 5-15 µm • Culture: has never been cultured. Non pathogenic strains (Reiter) can be cultured • Growth characteristics: microaerophilic Reiter strain grows on defined medium • Drying and 42°C kills the spirochete rapidly • Penicillin is treponemicidal • Genome is highly conserved, and does not have transposable elements Fontana tribondeau staining (silver nitrate) Electron micrograph of T. pallidum 2 2015-10-27 Antigenic structure • Membrane proteins • Endoflagella • Hyaluronidase Pathogenesis A. Acquired syphilis: limited to the human host through sexual contact • Skin or mucous membrane lesions • Primary lesions: In 2-10 weeks after infection, a papule develops and then an ulcer (hard chancre) • Infiltration of lymphocytes and plasma cells • Secondary lesions: red maculopapular rash anywhere on the body Pathogenesis • Both primary and secondary are rich in spirochetes and subside spontaneously • Tertiary lesions: development of granulomatous lesions (gummas) in skin, bones, and liver; degenerative changes in the CNS (neurosyphilis); or cardiovascular lesions • In tertiary lesions, treponemes are very rare 3 2015-10-27 Pathogenesis B. Congenital syphilis: A pregnant syphlitic woman can transmit T. pallidum C. Experimental disease: rabbits can be experimentally infected Diagnostic tests • Specimens: tissue fluid and blood • Dark-field examination • Immunofluorescence • Serologic tests Serologic tests for syphilis • The tests use either nontreponemal or treponemal antigens 1.
    [Show full text]
  • Patient Case Study By: Paul, Jen, Chris, & Ben Chris, Jen, Paul, By: a Second Hospital for a Possible Liver Transplantation
    Patient Case Study By: Paul, Jen, Chris, & Ben Case & Social History A 65 year old woman with presumed autoimmune hepatitis was transferred to a second hospital for a possible liver transplantation. ● Heavy drinker: 3-5 half gallons of distilled spirits per week ● Minor history of smoking ● Lived alone ● Indoor cat, no other animals ● No recent travel ● Worked in healthcare field ● Family history states no liver problems 6 years before admission to Massachusetts General Hospital Patient receives abnormal liver-function test - Additional testing reveals: - Elevated antinuclear antibody titer - Negative for viral hepatitis Doctors presume autoimmune hepatitis and cirrhosis from her heavy alcohol consumption: - Patient is prescribed glucocorticoids and stops drinking heavily 7 weeks before admission Patient experiences malaise, jaundice, fatigue and seeks treatment at another hospital. Various tests were performed, checking for... Antinuclear Antibody Titer ● Autoimmune responses resemble normal immune responses because they are specifically activated by antigens (like those by pathogens), except that in this case, the antigens are from the host, or self. ● These are called self-antigens, or autoantigens. ○ Give rise to autoreactive effector cells and antibodies ■ Termed: autoantibodies ● The antinuclear antibody is a subtype of autoantibody which attacks proteins in, and the nucleus of, the (host) cell. ● Therefore, elevated levels of antinuclear antibody titer reveals a potential autoimmune disease ○ This would explain the presumptive autoimmune
    [Show full text]
  • P|Lf Llte^?*F• ^J^'F'^'»:Y^-^Vv1;' • / ' ^;
    Poisonous Animals of the Desert Item Type text; Book Authors Vorhies, Charles T. Publisher College of Agriculture, University of Arizona (Tucson, AZ) Rights Public Domain: This material has been identified as being free of known restrictions under U.S. copyright law, including all related and neighboring rights. Download date 29/09/2021 16:26:58 Item License http://creativecommons.org/publicdomain/mark/1.0/ Link to Item http://hdl.handle.net/10150/194878 University of Arizona College of Agriculture Agricultural Experiment Station Bulletin No. 83 j ^.^S^^^T^^r^fKK' |p|p|lf llte^?*f• ^j^'f'^'»:Y^-^Vv1;' • / ' ^; Gila Monster. Photograph from life. About one-fifth natural size. Poisonous Animals of the Desert By Charles T. Vorhies Tucson, Arizona, December 20, 1917 UNIVERSITY OF ARIZONA AGRICULTURAL EXPERIMENT STATION GOVERNING BOARD (REGENTS OF THE UNIVERSITY) ttx-Officio His EXCELLENCY, THE GOVERNOR OF ARIZOX v THE STATE SUPERINTENDENT OF PUULIC INSTRUCTION Appointed by the Governor of the State WILLI\M V. WHITMORE, A. M., M. D Chancellor RUDOLPH R VSMESSEN Treasurer WILLIAM J. BRY VN, JR., A, B Secretary vViLLi \M Sc \RLETT, A. B-, B. D Regent JOHN P. ORME Regent E. TITCOMB Regent JOHN W. FUNN Regent CAPTAIN J. P. HODGSON Regent RLIFUS B. \ON KLEINSMITI, A. M., Sc. D President of the University Agricultural Staff ROBERT H. FORBES, Ph. D. Dean and Director JOHN J. THORNBER, A. M Botanist ALBERT E. VINSON, Ph. D Biochemist CLIFFORD N. CATLJN, A, M \ssistunt Chemist GEORGE E. P. SMITH, C. E Irrigation Engineer FRANK C. KELTON, M. S \ssistnnt Engineer GEORGE F.
    [Show full text]
  • Introduced B.,Byhansen, 16
    LB301 LB301 2021 2021 LEGISLATURE OF NEBRASKA ONE HUNDRED SEVENTH LEGISLATURE FIRST SESSION LEGISLATIVE BILL 301 Introduced by Hansen, B., 16. Read first time January 12, 2021 Committee: Judiciary 1 A BILL FOR AN ACT relating to the Uniform Controlled Substances Act; to 2 amend sections 28-401, 28-405, and 28-416, Revised Statutes 3 Cumulative Supplement, 2020; to redefine terms; to change drug 4 schedules and adopt federal drug provisions; to change a penalty 5 provision; and to repeal the original sections. 6 Be it enacted by the people of the State of Nebraska, -1- LB301 LB301 2021 2021 1 Section 1. Section 28-401, Revised Statutes Cumulative Supplement, 2 2020, is amended to read: 3 28-401 As used in the Uniform Controlled Substances Act, unless the 4 context otherwise requires: 5 (1) Administer means to directly apply a controlled substance by 6 injection, inhalation, ingestion, or any other means to the body of a 7 patient or research subject; 8 (2) Agent means an authorized person who acts on behalf of or at the 9 direction of another person but does not include a common or contract 10 carrier, public warehouse keeper, or employee of a carrier or warehouse 11 keeper; 12 (3) Administration means the Drug Enforcement Administration of the 13 United States Department of Justice; 14 (4) Controlled substance means a drug, biological, substance, or 15 immediate precursor in Schedules I through V of section 28-405. 16 Controlled substance does not include distilled spirits, wine, malt 17 beverages, tobacco, hemp, or any nonnarcotic substance if such substance 18 may, under the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.
    [Show full text]
  • International Classification of Diseases
    INTERNATIONAL CLASSIFICATION OF DISEASES MANUAL OF THE INTERNATIONAL STATISTICAL CLASSIFICATION OF DISEASES, INJURIES, AND CAUSES OF DEATH Based on the Recommendations of the Eighth Revision Conference, 1965, and Adopted by the Nineteenth World Health Assembly Volume 2 ALPHABETICAL INDEX WORLD HEALTH ORGANIZATION GENEVA 1969 Volume 1 Introduction List of Three-digit Categories Tabular List of Inclusions and Four-digit Sub- categories Medical Certification and Rules for Classification Special Lists for Tabulation Definitions and Recommendations Regulations Volume 2 Alphabetical Index PRINTED IN ENGLAND CONTENTS Introduction Page General arrangement of the Index ....................................... VIII Main sections ............................................................... VIII Structure ..................................................................... IX Code numbzrs .............................................................. x Primary and secondary conditions. ................................... x Multiple diagnoses. ........................................................ XI Spelling....................................................................... XI Order of listing ............................................................. Conventions used in the Index ........................................... XII Parentheses. ................................................................. XII Cross-referexes ........................................................... XI1 Abbreviation NEC. ......................................................
    [Show full text]
  • Introductory Material Table of Contents
    National Library of Medicine Classification 2019 Introductory Material Table of Contents Introduction to the NLM Classification .................................................................................. iii Scope of Revision ...................................................................................................................iii Historical Development ...........................................................................................................vi Structure of the NLM Classification ........................................................................................vi Relationship to MeSH® ..........................................................................................................vii Index .......................................................................................................................................vii NLM Classification Practices ..................................................................................................viii General ...................................................................................................................................viii Basic Rules .............................................................................................................................viii Form Numbers ........................................................................................................................viii Table G (Geographic Notation) .............................................................................................
    [Show full text]